Skip to main content

Opisthorchis Viverrini

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Pathogenesis of Liver Fluke Induced Cancer in ThailandN/A1 trial
Active Trials
NCT00472602Completed695Est. Apr 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Allergy TherapeuticsPathogenesis of Liver Fluke Induced Cancer in Thailand

Clinical Trials (1)

Total enrollment: 695 patients across 1 trials

NCT00472602Allergy TherapeuticsPathogenesis of Liver Fluke Induced Cancer in Thailand

Pathogenesis of Liver Fluke Induced Cancer in Thailand

Start: Aug 2007Est. completion: Apr 2012695 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.